Humana Inc (HUM)
26 Sep 2016
* Marketing process for company's 2016 medicare offerings begins on October 1, 2016, with enrollment beginning october 15, 2016
* Sets quarterly cash dividend of $0.29per share Source text for Eikon: Further company coverage:
NEW YORK Aetna Inc warned in July that it would exit much of the individual Obamacare health insurance market if the government challenged its deal to buy rival Humana Inc, according to a letter it sent to the U.S. Department of Justice.
NEW YORK Aetna Inc warned in July that it would exit much of the individual Obamacare health insurance market if the government challenged its deal to buy rival Humana Inc , according to a letter it sent to the U.S. Department of Justice. | Video
NEW YORK, Aug 17 Aetna Inc warned in July that it would exit much of the individual Obamacare health insurance market if the government challenged its deal to buy rival Humana Inc, according to a letter it sent to the U.S. Department of Justice.
NEW YORK, Aug 17 Aetna Inc's CEO said in a letter to the U.S. Department of Justice during the review of its deal to buy rival Humana Inc that the insurer would exit much of the individual Obamacare insurance market if the agency challenged the merger.
NEW YORK Aetna Inc, the No. 3 U.S. health insurer, on Monday said that due to persistent financial losses on Obamacare plans, it will sell individual insurance on the government-run online marketplaces in only four states next year, down from the current 15 states.
* Q2 FFO per share view c$0.14 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
(The following statement was released by the rating agency) CHICAGO, August 10 (Fitch) Fitch Ratings has affirmed UnitedHealth Group Incorporated's (UNH) Issuer Default Rating (IDR) at 'A' and its senior unsecured notes at 'A-'. Fitch has also affirmed the 'AA-' Insurer Financial Strength ratings of UNH's insurance company subsidiaries. The Rating Outlook remains Negative. A complete list of rating actions follows at the end of this release. KEY RATING DRIVERS The affirmation of UNH's ratin
The federal judge hearing the U.S. Justice Department's case to block Aetna Inc's $34 billion purchase of Humana Inc has set a trial date for Dec. 5, later than the companies had requested.
|UnitedHealth Group Inc (UNH.N)||$139.52||-0.99|
|Anthem Inc (ANTM.N)||$125.24||-1.32|
|Metlife Inc (MET.N)||$43.65||-0.87|
|Metlife Inc (MET_pa.N)||$25.28||-0.03|
|Metlife Inc (MLG)||--||--|
|Aetna Inc (AET.N)||$114.97||-0.66|
|Manulife Financial Corp. (MFC.TO)||$18.19||-0.30|
|Manulife Financial Corp. (MFC_pd.TO)||--||--|
|Manulife Financial Corp. (MFC_pe.TO)||--||--|
|AEGON N.V. (AEGN.AS)||€3.44||-0.11|
Earnings vs. Estimates
Analyst Research Reports
Trading Report for (HUM). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : Wright Reports
Provider : New Constructs, LLC
Provider : Thomson Reuters Stock Report
"The Economy Matters" Report for HUM: the economy's impact on HUM's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider : MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.